Cargando…

Preoperative Folate Receptor-Positive Circulating Tumor Cell Level Is a Prognostic Factor of Long Term Outcome in Non-Small Cell Lung Cancer Patients

BACKGROUND: Surgical resection is often the preferred treatment for non-small cell lung cancer (NSCLC) patients. Predictive biomarkers after surgery can help monitoring and treating patients promptly, so as to improve the clinical outcome. In this study, we evaluated one potential candidate biomarke...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hang, Li, Bin, Pan, Yunjian, Zhang, Yang, Xiang, Jiaqing, Zhang, Yawei, Sun, Yihua, Yu, Xiang, He, Wei, Hu, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876466/ https://www.ncbi.nlm.nih.gov/pubmed/33585249 http://dx.doi.org/10.3389/fonc.2020.621435

Ejemplares similares

The Prognostic Value of Preoperative Serum Tumor Markers in Non-Small Cell Lung Cancer Varies With Radiological Features and Histological Types
por: Chen, Haiqing, et al.
Publicado: (2021)

Preoperative levels of folate receptor-positive circulating tumor cells in different subtypes of early-stage lung adenocarcinoma: Predictive value for determining extent of surgical resection
por: Zhou, Chao, et al.
Publicado: (2023)

Preoperative Folate Receptor-Positive Circulating Tumor Cells Are Associated With Occult Peritoneal Metastasis and Early Recurrence in Gastric Cancer Patients: A Prospective Cohort Study
por: Zeng, Ci Dian Dan, et al.
Publicado: (2022)

Folate-Receptor Positive Circulating Tumor Cell Is a Potential Diagnostic Marker of Prostate Cancer
por: Lian, Shenyi, et al.
Publicado: (2021)

Folate receptor‐positive circulating tumor cells in the preoperative diagnosis of indeterminate pulmonary nodules
por: Li, Zhixin, et al.
Publicado: (2022)

Folate receptor-positive circulating tumor cells predict survival and recurrence patterns in patients undergoing resection for pancreatic cancer
por: Cheng, Hao, et al.
Publicado: (2022)

Efficacy and safety of neoadjuvant chemotherapy and immunotherapy in locally resectable advanced esophageal squamous cell carcinoma
por: Wu, Zhigang, et al.
Publicado: (2021)

Circulating Tumor DNA as a Prognostic Biomarker in Localized Non-small Cell Lung Cancer
por: Peng, Muyun, et al.
Publicado: (2020)

Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: Perioperative and Survival Outcomes
por: Ma, Xiao, et al.
Publicado: (2022)

The value of folate receptor‐positive circulating tumor cells in the diagnosis of lung cancer and its correlation with clinical characteristics
por: Xu, Yunjian, et al.
Publicado: (2023)

Folate receptor-positive circulating tumor cell count, lymphocyte count and derived neutrophil-to- lymphocyte ratio for diagnosing lung cancer relapse
por: Wang, Huanrong, et al.
Publicado: (2023)

Small bowel necrosis after esophagectomy
por: Shao, Longlong, et al.
Publicado: (2023)

When Should (99m)Tc Bone Scintigraphy Be Performed in cT1N0 Non-Small Cell Lung Cancer Patients?
por: Li, Hang, et al.
Publicado: (2015)

Association of Preoperative NANOG-Positive Circulating Tumor Cell Levels With Recurrence of Hepatocellular Carcinoma
por: Lei, Yongrong, et al.
Publicado: (2021)

Evaluation of colorectal cancer liver metastases based on liquid biopsy combined with folate receptor– Positive circulating tumor cells and HSP90
por: Huang, Maosen, et al.
Publicado: (2022)

Predictive and prognostic value of folate receptor-positive circulating tumor cells in small cell lung cancer patients treated with first-line chemotherapy
por: Shen, Jiqiao, et al.
Publicado: (2017)

Circulating Long Noncoding RNAs Act as Diagnostic Biomarkers in Non-Small Cell Lung Cancer
por: Yuan, Shuai, et al.
Publicado: (2020)

Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction
por: Li, Hecheng, et al.
Publicado: (2009)

Clinical Utility of Circulating Tumor Cells in ALK-Positive Non-Small-Cell Lung Cancer
por: Faugeroux, Vincent, et al.
Publicado: (2014)

Clinical and genetic features of lung squamous cell cancer in never-smokers
por: Huang, Yangle, et al.
Publicado: (2016)

The utility of folate receptor-positive circulating tumor cell in cancer diagnosis in the elderly population
por: Li, Na, et al.
Publicado: (2019)

Detection of folate receptor‐positive circulating tumor cells as a biomarker for diagnosis, prognostication, and therapeutic monitoring in breast cancer
por: Wu, Qian, et al.
Publicado: (2021)

Circulating tumor DNA detection in MRD assessment and diagnosis and treatment of non-small cell lung cancer
por: Fang, Xiaoxu, et al.
Publicado: (2022)

Circulating tumor cells as a preoperative risk marker for occult metastases in patients with resectable cholangiocarcinoma
por: Fründt, Thorben, et al.
Publicado: (2022)

Small Cell Size Circulating Aneuploid Cells as a Biomarker of Prognosis in Resectable Non-Small Cell Lung Cancer
por: Hong, Yang, et al.
Publicado: (2021)

Pattern of tumor regression after neoadjuvant chemoimmunotherapy for esophageal squamous cell carcinoma
por: Li, Bin, et al.
Publicado: (2023)

Preoperative diagnosis of solitary pulmonary nodules with a novel hematological index model based on circulating tumor cells
por: Zhou, Qiuxi, et al.
Publicado: (2023)

Application of Circulating Tumor DNA as a Biomarker for Non-Small Cell Lung Cancer
por: Yang, Jialiang, et al.
Publicado: (2021)

The prognostic role of circulating tumor cells in gastric cancer: A meta-analysis
por: Li, Zuxi, et al.
Publicado: (2022)

Combination of Preoperative Circulating Tumor Cell Count and Neutrophil-Lymphocyte Ratio for Prognostic Prediction in Hepatocellular Carcinoma Patients after Curative Hepatectomy
por: Ni, Hang-Hang, et al.
Publicado: (2022)

The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer
por: Kapeleris, Joanna, et al.
Publicado: (2018)

Is (99m)Tc bone scintigraphy necessary in the preoperative workup for patients with cT1N0 subsolid lung cancer? A prospective multicenter cohort study
por: Li, Hang, et al.
Publicado: (2020)

Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer
por: Hanssen, Annkathrin, et al.
Publicado: (2015)

Prognostic Importance of the Preoperative Naples Prognostic Score for Patients With Adenocarcinoma of the Esophagogastric Junction
por: Xiong, Jianping, et al.
Publicado: (2020)

Prognostic Values of Preoperative Inflammatory and Nutritional Markers for Colorectal Cancer
por: Zhang, Nannan, et al.
Publicado: (2020)

Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer—An Update
por: Kapeleris, Joanna, et al.
Publicado: (2022)

Prognostic value of miR-219-5p in relation to mortality in patients with small cell lung cancer: a retrospective, observational cohort study in China
por: Wu, Xiangmei, et al.
Publicado: (2023)

Prognostic Value of Vimentin Is Associated With Immunosuppression in Metastatic Renal Cell Carcinoma
por: Yao, Jia xi, et al.
Publicado: (2020)

Epithelial-Mesenchymal-Transition-Like Circulating Tumor Cell-Associated White Blood Cell Clusters as a Prognostic Biomarker in HR-Positive/HER2-Negative Metastatic Breast Cancer
por: Guan, Xiuwen, et al.
Publicado: (2021)

Circulating miR-320a Acts as a Tumor Suppressor and Prognostic Factor in Non-small Cell Lung Cancer
por: Khandelwal, Akanksha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5p5enjtv4qit2qmgpr0fvk32ct